. Show Affiliations »
Abstract
Mesh： See more » Antithrombins/adverse effectsAntithrombins/therapeutic useAzetidines/adverse effectsAzetidines/therapeutic useBenzylaminesDrug ApprovalDrug IndustryUnited StatesUnited States Food and Drug Administration
Substances： See more » AntithrombinsAzetidinesBenzylaminesximelagatran
Year: 2004 PMID： 15451201 DOI： 10.1016/S0140-6736(04)17113-4
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321